Employees are lukewarm on new locations and a slow-down in work rate will mean less income. In the best case scenario Europe’s drugs regulator will take 2-3 years to get back to speed after leaving London.
Only 5 of 19 cities bidding to host the European Medicines Agency would attract enough current employees for operations to continue as normal. Moving to one of the 8 least popular cities risks permanent damage, the agency warns
The UK wants a close relationship with EU science after Brexit. But there is much work to do if the UK government is to succeed in forging a closer partnership with the EU than exists with any other non-EU member
Strategy report calls for funding to create new industries, increased collaboration between pharmaceutical companies and the National Health Service, and incentives to keep the UK attractive to world class scientists after it leaves the EU
With a flimsy majority and some of its own MPs in favour of staying in Euratom, the UK government is talking of an “association agreement”. But ending European Court of Justice oversight remains as the red line